Flow cytometry is a methodology that allows performing simultaneous multi-parametric analysis of single cells in solution. Flow cytometers utilize lasers as light sources to produce both scattered and fluorescent light signals. Cell populations can be characterized and/or purified based on their fluorescent or light scattering characteristics.
Protein expression on cell surface and intracellular molecules can be detected using appropriate fluorescent probes. This technology can be also applied in medium-throughput screening to study the interaction of compounds for a target of interest, for instance by competition binding.
-
CELT-074 hD2 dopamine receptor fluorescent antagonist (589/616)
Our potent hD2 dopamine receptor fluorescent antagonist is available in a 10 µg vial, allowing you to prepare 73 mL of 100 nM working solution to test D2R.
432,00€ View more
Our CELT-074 product has been specifically designed to meet the needs of researchers in a variety of fields, enabling the study of D2 dopamine receptors with greater accuracy and precision -
CELT-426 hD2 dopamine receptor fluorescent antagonist (560/571)
Our CELT-426 product is available in a 10 µg vial that allows you to prepare 62 mL of 100 nM working solution to test D2R.
432,00€ View more
It has been specifically designed for high potency and selectivity, demonstrating a high affinity for D2 receptor and may be suitable for fluorescence-based assays -
CELT-240 hD2/D3 dopamine receptors fluorescent ligand (589/616)
Our CELT-240 product is available in a 10 µg vial that allows you to prepare 78 mL of 100 nM working solution to test D2R/D3R.
432,00€ View more
It demonstrates high potency and selectivity, making it a valuable tool for researchers interested in studying the D2 and D3 receptors
Do you want more information?
If you want to know more about how to use fluorescent ligands to characterize receptors with pharmacological interest with this and other technologies, click on the button to download the article “Fluorescent ligands: A new method to label your GPCRs”